Titlebook: Orphan Lung Diseases; A Clinical Guide to Vincent Cottin,Jean-Francois Cordier,Luca Richeldi Book 20151st edition Springer-Verlag London 2

FLAK

書目名稱Orphan Lung Diseases影響因子(影響力)




書目名稱Orphan Lung Diseases影響因子(影響力)學(xué)科排名




書目名稱Orphan Lung Diseases網(wǎng)絡(luò)公開度




書目名稱Orphan Lung Diseases網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Orphan Lung Diseases被引頻次




書目名稱Orphan Lung Diseases被引頻次學(xué)科排名




書目名稱Orphan Lung Diseases年度引用




書目名稱Orphan Lung Diseases年度引用學(xué)科排名




書目名稱Orphan Lung Diseases讀者反饋




書目名稱Orphan Lung Diseases讀者反饋學(xué)科排名

BANAL

receptors

Exogenous Lipoid Pneumonia,o show presence of intrapulmonary oil, such as bronchoalveolar lavage or histological specimens of which fat stains will be used..Endogenous lipid pneumonia must be eliminated..Early recognition and discontinuation of exposure are essential to prevent the lesions from evolving towards fibrosis and respiratory failure.

carbohydrate

Pulmonary Alveolar Proteinosis,is. Whole-lung lavage is the most effective, rapid and demonstrated therapy, especially for autoimmune disease. Novel therapies targeting alveolar macrophages (recombinant GM-CSF therapy) or anti-GM-CSF antibodies (rituximab, plasmapheresis) may be of interest.

熒光

The Challenges of Clinical Research in Orphan Diseases,iseases field..In this chapter we discuss ethical, social, economic and scientific needs for research into rare diseases and suggest that an even closer collaboration between patients, authorities and industry represents the way forward for generating more research in this field.

anus928

CHURL

Amyloidosis and the Respiratory Tract,Encouragingly, specific drug therapies designed to stabilize amyloid precursor proteins, interfere with amyloid fibrillogenesis and accelerate the clearance of tissue amyloid deposits are all on the horizon.

theta-waves

occult

Orphan Lung Diseases from Definition to Organisation of Care, the more distressing manifestations. The patients with rare diseases thus feel abandoned and orphan when comparing with patients with common diseases who benefit from extensive research worldwide and continuous drug development.

Diatribe